ATE293628T1 - Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel - Google Patents

Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel

Info

Publication number
ATE293628T1
ATE293628T1 AT00953480T AT00953480T ATE293628T1 AT E293628 T1 ATE293628 T1 AT E293628T1 AT 00953480 T AT00953480 T AT 00953480T AT 00953480 T AT00953480 T AT 00953480T AT E293628 T1 ATE293628 T1 AT E293628T1
Authority
AT
Austria
Prior art keywords
ring
denotes
substituted
group
optionally substituted
Prior art date
Application number
AT00953480T
Other languages
English (en)
Inventor
Shigenori Ohkawa
Tadatoshi Hashimoto
Tetsuya Tsukamoto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE293628T1 publication Critical patent/ATE293628T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
AT00953480T 1999-08-20 2000-08-18 Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel ATE293628T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23471999 1999-08-20
PCT/JP2000/005524 WO2001014385A1 (en) 1999-08-20 2000-08-18 Dihydrobenzofuran derivatives, process for the preparation thereof and agents

Publications (1)

Publication Number Publication Date
ATE293628T1 true ATE293628T1 (de) 2005-05-15

Family

ID=16975313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953480T ATE293628T1 (de) 1999-08-20 2000-08-18 Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel

Country Status (7)

Country Link
US (1) US7008940B1 (de)
EP (1) EP1213290B1 (de)
AT (1) ATE293628T1 (de)
AU (1) AU6595000A (de)
CA (1) CA2382418A1 (de)
DE (1) DE60019619T2 (de)
WO (1) WO2001014385A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4369924B2 (ja) 2003-04-14 2009-11-25 日本曹達株式会社 ジアミン誘導体、製造法及び抗酸化薬
US7465815B2 (en) * 2003-06-26 2008-12-16 Takeda Pharmaceutical Company Limited Cannabinoid receptor modulator
JPWO2005095431A1 (ja) * 2004-03-31 2008-02-21 株式会社クラレ ５α−プレグナン誘導体の製造方法
US20070149494A1 (en) * 2004-03-31 2007-06-28 Kuraray Co., Ltd. Method for producing 5alpha-pregnane derivative
EP2246326A1 (de) * 2009-05-02 2010-11-03 Bayer CropScience AG Verfahren zur Herstellung von Oxindolen und ortho-substituierten Anilinen und ihre Verwendung als Zwischenprodukte für Synthesen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163598A (en) 1978-06-13 1979-12-26 Daiichi Seiyaku Co Pyridoquinoline derivative
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
JP3406600B2 (ja) * 1992-05-01 2003-05-12 興和株式会社 キノリン誘導体又はその塩，及びこれを含有する心疾患治療剤
FR2713636B1 (fr) 1993-12-07 1996-01-05 Adir Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
US5856124A (en) 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
US6071946A (en) 1994-10-21 2000-06-06 Adir Et Compagnie Tricyclic urea compounds
US5998461A (en) 1994-10-21 1999-12-07 Adir Et Compagnie Tricyclic amide compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5661186A (en) 1995-02-24 1997-08-26 Bristol-Myers Squibb Co. Tetralinyl-and indanyl-ethylamides
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
CA2241666C (en) 1996-03-08 2007-11-06 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP1211253B1 (de) 1999-08-20 2004-10-13 Takeda Chemical Industries, Ltd. Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel

Also Published As

Publication number Publication date
EP1213290A4 (de) 2002-09-04
CA2382418A1 (en) 2001-03-01
WO2001014385A1 (en) 2001-03-01
DE60019619D1 (de) 2005-05-25
DE60019619T2 (de) 2006-03-02
AU6595000A (en) 2001-03-19
EP1213290B1 (de) 2005-04-20
EP1213290A1 (de) 2002-06-12
US7008940B1 (en) 2006-03-07

Similar Documents

Publication Publication Date Title
DE69111029D1 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
EP1103552A4 (de) Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
EA199800794A1 (ru) Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
EP1471064A4 (de) Cumarinderivate, verfahren zu deren herstellung und deren verwendung
ATE84787T1 (de) Prolin-derivate.
EP0881220A4 (de) Diarylsultam-derivate
DK1034174T3 (da) Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
ATE194982T1 (de) Benzoxazepin-derivate als cholinesterase- inhibitoren
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP1213290A4 (de) Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
ATE214059T1 (de) 4,6-di-t-butyl-2,3-dihydrobenzothiophene, die ldl oxidation hemmen
DE60014936D1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE233741T1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
DE69425970D1 (de) Benzol-derivate, verwendbar für ischämische erkrankungen
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
EA200101170A1 (ru) Галоидпроизводные 9-деоксо-9а-аза-9а-гомоэритромицина а
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
ATE384717T1 (de) Stereoisomere indolderivate, verfahren zu ihrer herstellung und ihre verwendung
KR900001696A (ko) 궤양치료 활성을 갖는 1.4-디아제핀 유도체

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties